STOCK TITAN

Akebia Therapeutics to Report First Quarter 2024 Financial Results and Discuss Recent Business Highlights

(Neutral)
(Neutral)
Tags
conferences earnings

Rhea-AI Summary

Akebia Therapeutics, Inc. (Nasdaq: AKBA) will release its first-quarter financial results on May 9, 2024, and host a conference call to discuss the results and recent business highlights. The call is scheduled for 8:00 a.m. ET. Investors can access the call via phone or webcast.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

News Market Reaction – AKBA

+4.84%
+4.84% Session move

In the trading session that priced this news, AKBA gained 4.84%, reflecting a moderate positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

Akebia to Host Conference Call on May 9, 2024, at 8:00 a.m. ET

CAMBRIDGE, Mass., May 2, 2024 /PRNewswire/ -- Akebia Therapeutics®, Inc. (Nasdaq: AKBA) today announced plans to release its financial results for the first quarter ended March 31, 2024, on Thursday, May 9, 2024, prior to the open of financial markets.

Akebia will host a conference call on Thursday, May 9, 2024, at 8:00 a.m. ET to discuss its financial results and recent business highlights. To access the call by phone, please click on this Registration Link and you will be provided with dial in details. To avoid delays, we encourage dialing into the conference call fifteen minutes ahead of the scheduled start time.

A live webcast of the conference call will be available via the Investors section of Akebia's website at: https://ir.akebia.com/. An online archive of the webcast can be accessed via the Investors section of Akebia's website at http://ir.akebia.com.

About Akebia Therapeutics
Akebia Therapeutics, Inc. is a fully integrated biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease. Akebia was founded in 2007 and is headquartered in Cambridge, Massachusetts. For more information, please visit our website at www.akebia.com, which does not form a part of this release.

Akebia Therapeutics Contact
Mercedes Carrasco
mcarrasco@akebia.com

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/akebia-therapeutics-to-report-first-quarter-2024-financial-results-and-discuss-recent-business-highlights-302134491.html

SOURCE Akebia Therapeutics, Inc.

FAQ

When will Akebia Therapeutics release its first-quarter financial results?

Akebia Therapeutics will release its first-quarter financial results on May 9, 2024.

When is the conference call scheduled to discuss the financial results and recent business highlights?

The conference call is scheduled for May 9, 2024, at 8:00 a.m. ET.

How can investors access the conference call?

Investors can access the conference call by phone or via the live webcast available on Akebia's website.